These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37849962)

  • 1. Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltration.
    Tian Y; Kong L; Li Y; Liao Z; Cai X; Deng S; Yang X; Zhang B; Wang Y; Zhang Z; Wu B; Wen L; Huang F; Hu Y; Wan C; Liao Y; Sun Y; Yang K
    Oncoimmunology; 2023; 12(1):2268257. PubMed ID: 37849962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
    Barreira da Silva R; Laird ME; Yatim N; Fiette L; Ingersoll MA; Albert ML
    Nat Immunol; 2015 Aug; 16(8):850-8. PubMed ID: 26075911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl Peptidase 4/Midline-1 Axis Promotes T Lymphocyte Motility in Atherosclerosis.
    Rao X; Razavi M; Mihai G; Wei Y; Braunstein Z; Frieman MB; Sun XJ; Gong Q; Chen J; Zhao G; Liu Z; Quon MJ; Dong L; Rajagopalan S; Zhong J
    Adv Sci (Weinh); 2023 Mar; 10(9):e2204194. PubMed ID: 36683148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
    Hollande C; Boussier J; Ziai J; Nozawa T; Bondet V; Phung W; Lu B; Duffy D; Paradis V; Mallet V; Eberl G; Sandoval W; Schartner JM; Pol S; Barreira da Silva R; Albert ML
    Nat Immunol; 2019 Mar; 20(3):257-264. PubMed ID: 30778250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice.
    Nistala R; Meuth AI; Smith C; An J; Habibi J; Hayden MR; Johnson M; Aroor A; Whaley-Connell A; Sowers JR; McKarns SC; Bender SB
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F505-F517. PubMed ID: 33522410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer.
    Zuo B; Li T; Liu X; Wang S; Cheng J; Liu X; Cui W; Shi H; Ling C
    Clin Transl Oncol; 2023 Nov; 25(11):3188-3202. PubMed ID: 37115489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Thyroid DPP4 Expression Is Associated With Inflammatory Process in Patients With Hashimoto Thyroiditis.
    Wen X; Chang X; He X; Cai Q; Wang G; Liu J
    J Clin Endocrinol Metab; 2024 May; 109(6):1517-1525. PubMed ID: 38127960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
    He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
    Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
    [No Abstract]   [Full Text] [Related]  

  • 12. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway.
    Chen Z; Yu J; Fu M; Dong R; Yang Y; Luo J; Hu S; Li W; Xu X; Tu L
    Biochem Pharmacol; 2020 Jul; 177():113951. PubMed ID: 32251672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
    Shao S; Xu Q; Yu X; Pan R; Chen Y
    Pharmacol Ther; 2020 May; 209():107503. PubMed ID: 32061923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Dipeptidyl Peptidase-4 in cutaneous disease.
    Patel PM; Jones VA; Kridin K; Amber KT
    Exp Dermatol; 2021 Mar; 30(3):304-318. PubMed ID: 33131073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism.
    Yang Q; Fu B; Luo D; Wang H; Cao H; Chen X; Tian L; Yu X
    Front Endocrinol (Lausanne); 2022; 13():856954. PubMed ID: 35586625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
    Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
    Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies.
    Decalf J; Tarbell KV; Casrouge A; Price JD; Linder G; Mottez E; Sultanik P; Mallet V; Pol S; Duffy D; Albert ML
    EMBO Mol Med; 2016 Jun; 8(6):679-83. PubMed ID: 27137491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors.
    Matteucci E; Giampietro O
    Curr Med Chem; 2015; 22(13):1573-81. PubMed ID: 25723507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review.
    Torrecillas-Baena B; Gálvez-Moreno MÁ; Quesada-Gómez JM; Dorado G; Casado-Díaz A
    Stem Cell Rev Rep; 2022 Jan; 18(1):56-76. PubMed ID: 34677817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.